Delivery Order SPE2DB20D2104-SPE2DB24FR66D
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,352.40 for the pharmaceutical product ENBREL 50 MG/ML SURECLICK. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on October 27, 2021, with an ultimate completion date of October 28, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $23,180.97, is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 27, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The $13,022.74 firm fixed-price delivery order contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,492.26, is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and the parent company holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Enbrel 50 mg/ml SureClick medication to DLA Troop Support Medical facilities. The $7,187.22 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 19, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $26,717.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 8, 2024, with a completion date of March 11, 2024. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $15,329.68. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENBREL 50 MG/ML SURECLICKML. The award, valued at $81,942.12, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is a delivery order valued at $73,566.16 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of ENBREL 50 MG/ML SURECLICKML, a medication, with a completion date of September 24, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of ENBREL 50 MG/ML SURECLICK pharmaceutical products. The firm-fixed-price delivery order, valued at $19,266.88, has a completion date of January 26, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR66DDelivery Order
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,747.91, is a firm fixed price delivery order with a completion date of December 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 12/15/23 |